Family Medicine Doctors in Grants Pass, OR Accepting Medicare

45 Family Medicine doctors found. Showing 41 - 45

Dr. Thomas Martin Turek, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 124 Midland Ave., Grants Pass, OR 97526 Phone: 541-474-5664

Dr. Randall Currier, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Sw Ramsey Ave, Grants Pass, OR 97527 Phone: 541-472-7000    Fax: 541-474-4502

Dr. Linford Shenk Beachy, BA, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Nw Hawthorne Ave, Grants Pass, OR 97526 Phone: 541-471-3455

Dr. Leona O'keefe, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1701 Nw Hawthorne Ave, Grants Pass, OR 97526 Phone: 541-472-4777    Fax: 541-471-1439

Dr. Caroline Jean Brown, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 495 Ramsey Ave, Grants Pass, OR 97527 Phone: 541-476-6644    Fax: 541-472-5673

News Archive

AGT2R gene variant may predispose women to pre-eclampsia

New research at the University of Adelaide has revealed a genetic link in pregnant mums - and their male partners - to pre-eclampsia, a life-threatening complication during pregnancy.

Effects of lead in petrol are well-known however a recent additive to petrol manganese may be just as toxic

The disastrous environmental and health effects of lead in petrol are well-known, and western countries have been phasing it out for many years now. However, a recent additive to petrol - manganese - may be just as toxic. A Macquarie University study aims to find out.

Agilent's GeneSpring Bioinformatics Solution integrated with GeneGo's MetaCore

GeneGo, Inc., a leading provider of databases, software and services in systems biology and chemistry, and Agilent Technologies, Inc., the world's premier measurement company and a technology leader in chemical analysis, life sciences, electronics and communications, announced today that they have integrated Agilent's GeneSpring Bioinformatics Solution with MetaCore.

ADVENTRX seeks meeting with FDA to discuss ANX-514 docetaxel emulsion study findings

ADVENTRX Pharmaceuticals, Inc. today announced it has submitted a request to the U.S. Food and Drug Administration (FDA) to schedule a meeting for the purpose of discussing its product candidate ANX-514 (docetaxel emulsion for injection). The FDA is expected to set the meeting date within 60 days of receiving the request from ADVENTRX.

Binge drinking may slow recovery and increase medical costs for survivors of burn injuries

A Loyola University Medical Center study has found that binge drinking may slow recovery and increase medical costs for survivors of burn injuries. The study was presented during the 44th Annual Meeting of the American Burn Association in Seattle.

Read more Medical News

› Verified 2 days ago

• 1
• 2
• 3(current)